Crystal Structure of an Integrin-binding Fragment of Vascular Cell Adhesion Molecule-1 at 1.8 A Resolution
Authors
Affiliations
The cell-surface glycoprotein vascular cell adhesion molecule-1 (VCAM-1; ref. 1) mediates intercellular adhesion by specific binding to the integrin very-late antigen-4 (VLA-4, alpha 4 beta 1; ref. 3). VCAM-1, with the intercellular adhesion molecules ICAM-1, ICAM-2, ICAM-3 and the mucosal vascular addressin MAd-CAM-1, forms an integrin-binding subgroup of the immunoglobulin superfamily. In addition to their clinical relevance in inflammation, these molecules act as cellular receptors for viral and parasitic agents. The predominant form of VCAM-1 in vivo has an amino-terminal extracellular region comprising seven immunoglobulin-like domains. Functional studies have identified a conserved integrin-binding motif in domains 1 and 4, variants of which are present in the N-terminal domain of all members of the immunoglobulin superfamily subgroup. We report here the crystal structure of a VLA-4-binding fragment composed of the first two domains of VCAM-1. The integrin-binding motif (Q38IDSPL) is highly exposed and forms the N-terminal region of the loop between beta-strands C and D of domain 1. This motif exhibits a distinctive conformation which we predict will be common to all the integrin-binding IgSF molecules. These, and additional data, map VLA-4 binding to the face of the CFG beta-sheet, the surface previously identified as the site for intercellular adhesive interactions between members of the immunoglobulin superfamily.
Lima C, Eto S, Lopes-Ferreira M Pharmaceuticals (Basel). 2022; 15(8).
PMID: 36015142 PMC: 9412873. DOI: 10.3390/ph15080994.
Perinatal Inflammation: Could Partial Blocking of Cell Adhesion Molecule Function Be a Solution?.
Vrachnis N, Zygouris D, Vrachnis D, Roussos N, Loukas N, Antonakopoulos N Children (Basel). 2021; 8(5).
PMID: 34065912 PMC: 8150343. DOI: 10.3390/children8050380.
Day K, Schneible J, Young A, Pozdin V, Van Den Driessche G, Gaffney L J Mater Chem B. 2020; 8(33):7413-7427.
PMID: 32661544 PMC: 7945681. DOI: 10.1039/d0tb01189d.
Novel Ligands Targeting αβ Integrin: Therapeutic Applications and Perspectives.
Baiula M, Spampinato S, Gentilucci L, Tolomelli A Front Chem. 2019; 7:489.
PMID: 31338363 PMC: 6629825. DOI: 10.3389/fchem.2019.00489.
Melandri D, Zlatareva I, Chaleil R, Dart R, Chancellor A, Nussbaumer O Nat Immunol. 2018; 19(12):1352-1365.
PMID: 30420626 PMC: 6874498. DOI: 10.1038/s41590-018-0253-5.